NANOMETICS, LLC

Basic Information

50 E 8TH ST, STE 6N
NEW YORK, NY, 10003-6524

Company Profile

n/a

Additional Details

Field Value
DUNS: 831297770
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Orally available transition state inhibitors for triple negative breast cancer

    Amount: $225,000.00

    Problem to be Solved: Triple-negative breast cancer (TNBC) is a deadly disease that accounts for 15-20% of all diagnosed breast cancers worldwide. Metastatic relapse of TNBC carries a poorer prognosis ...

    STTR Phase I 2014 Department of Health and Human Services
  2. Organocatalysis for the treatment of sickle cell disease

    Amount: $2,595,637.00

    DESCRIPTION (provided by applicant): Sickle cell disease (SCD) is a global health issue that affects ~100,000 Americans and over 13 million people worldwide. The complexity of the disease dictates tha ...

    SBIR Phase II 2013 Department of Health and Human Services
  3. Schiff base forming sunscreen filters for long-wear UV protection

    Amount: $250,540.00

    DESCRIPTION (provided by applicant): Problem to be solved: Skin cancer is the most common of all cancers, accounting for nearly half of all reported cancer cases in the USA. According to the American ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Organocatalysis for the Treatment of Sickle Cell Disease.

    Amount: $243,469.00

    DESCRIPTION (provided by applicant): One potential therapeutic approach to treat sickle cell disease (SCD) involves the administration of aryl aldehyde-containing small molecules that form Schiff base ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government